Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2012 3
2013 6
2014 9
2015 5
2016 5
2017 2
2018 1
2020 3
2021 1
2022 3
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Copper deficiency.
Chhetri SK, Mills RJ, Shaunak S, Emsley HC. Chhetri SK, et al. BMJ. 2014 Jun 17;348:g3691. doi: 10.1136/bmj.g3691. BMJ. 2014. PMID: 24938531 No abstract available.
Diagnosing ALS: the Gold Coast criteria and the role of EMG.
Turner MR; UK MND Clinical Studies Group. Turner MR, et al. Pract Neurol. 2022 Jun;22(3):176-178. doi: 10.1136/practneurol-2021-003256. Epub 2022 Jan 6. Pract Neurol. 2022. PMID: 34992096 Free PMC article. No abstract available.
A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial.
Lombardo FL, Spila Alegiani S, Mayer F, Cipriani M, Lo Giudice M, Ludolph AC, McDermott CJ, Corcia P, Van Damme P, Van den Berg LH, Hardiman O, Nicolini G, Vanacore N, Dickie B, Albanese A, Puopolo M; TUDCA-ALS Study Group. Lombardo FL, et al. Trials. 2023 Dec 5;24(1):792. doi: 10.1186/s13063-023-07638-w. Trials. 2023. PMID: 38053196 Free PMC article. Clinical Trial.
Swallow syncope unravelled by fizzy drink challenge.
Chhetri SK, Khan S, Nixon J. Chhetri SK, et al. QJM. 2016 May;109(5):341-2. doi: 10.1093/qjmed/hcw024. Epub 2016 Mar 9. QJM. 2016. PMID: 26961552 Free PMC article. No abstract available.
Reversible pseudoathetosis induced by cervical myelopathy.
Bray K, Chhetri SK, Varma A, Silverdale M. Bray K, et al. Among authors: chhetri sk. Mov Disord. 2012 Sep 15;27(11):1370-1. doi: 10.1002/mds.24891. Mov Disord. 2012. PMID: 23001935 No abstract available.
Acceptance and Commitment Therapy plus usual care for improving quality of life in people with motor neuron disease (COMMEND): a multicentre, parallel, randomised controlled trial in the UK.
Gould RL, McDermott CJ, Thompson BJ, Rawlinson CV, Bursnall M, Bradburn M, Kumar P, Turton EJ, White DA, Serfaty MA, Graham CD, McCracken LM, Goldstein LH, Al-Chalabi A, Orrell RW, Williams T, Noad R, Baker I, Faull C, Lambert T, Chhetri SK, Ealing J, Hanratty A, Radunovic A, Gunawardana N, Meadows G, Gorrie GH, Young T, Lawrence V, Cooper C, Shaw PJ, Howard RJ; COMMEND Collaboration Group. Gould RL, et al. Among authors: chhetri sk. Lancet. 2024 Jun 1;403(10442):2381-2394. doi: 10.1016/S0140-6736(24)00533-6. Epub 2024 May 9. Lancet. 2024. PMID: 38735299 Free article. Clinical Trial.
38 results